Tenders Are Invited For Pharmaceutical Products – Conclusion Of A Non-Exclusive Discount Contract According To 130C Paragraph 1 Sgb V For The Period From April 1St, 2026 To Usually March 31St, 2028

Pharmaceutical Products – Conclusion Of A Non-Exclusive Discount Contract According To 130C Paragraph 1 Sgb V For The Period From April 1St, 2026 To Usually March 31St, 2028. This Announcement Serves To Conclude Drug Discount Agreements In Accordance With Section 130C Paragraph 1 Sgb V For The Active Ingredient(S) Mentioned Under The Title. This Does Not Involve The Awarding Of Public Contracts Within The Meaning Of Directive 2014/24/Eu Or Sections 97 Ff Gwb. Any Pharmaceutical Company Can Become A Contractual Partner In Accordance With Section 4 Paragraph 18 Amg. According To The Case Law Of The Ecj, Such Approval Procedures Are Not Necessarily Subject To Public Procurement Law, Since No Competition Takes Place Due To The Lack Of A Selection Decision. The Announcement Serves As An Invitation To Conclude Discount Agreements With Conditions That Apply Equally To All Contractual Partners And Are Not Subject To Discretion, Including The Determination Of The Discount. The Contract Is Concluded By Signing The Contract Documents And Submitting The Required Declarations, Which Can Be Requested From The Designated Contact Point.